PLCB2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2
Also known as: FLJ38135, PLCB2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q00722
- Gene
- PLCB2
- Ensembl
- ENSG00000137841
- Chromosome
- 15
- Canonical length
- 1185 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Plasma membrane,Basal body,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a phosphodiesterase that catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate to the second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol. The encoded protein is activated by G proteins and has been shown to be involved in the type 2 taste receptor signal transduction pathway. In addition, nuclear factor kappa B can regulate the transcription of this gene, whose protein product is also an important regulator of platelet responses. [provided by RefSeq, Jan 2017]
Canonical amino-acid sequenceUniProt
1185 residues, UniProt reviewed canonical sequence.
>Q00722|PLCB2
1 MSLLNPVLLP PKVKAYLSQG ERFIKWDDET TVASPVILRV DPKGYYLYWT YQSKEMEFLD
61 ITSIRDTRFG KFAKMPKSQK LRDVFNMDFP DNSFLLKTLT VVSGPDMVDL TFHNFVSYKE
121 NVGKAWAEDV LALVKHPLTA NASRSTFLDK ILVKLKMQLN SEGKIPVKNF FQMFPADRKR
181 VEAALSACHL PKGKNDAINP EDFPEPVYKS FLMSLCPRPE IDEIFTSYHA KAKPYMTKEH
241 LTKFINQKQR DSRLNSLLFP PARPDQVQGL IDKYEPSGIN AQRGQLSPEG MVWFLCGPEN
301 SVLAQDKLLL HHDMTQPLNH YFINSSHNTY LTAGQFSGLS SAEMYRQVLL SGCRCVELDC
361 WKGKPPDEEP IITHGFTMTT DIFFKEAIEA IAESAFKTSP YPIILSFENH VDSPRQQAKM
421 AEYCRTIFGD MLLTEPLEKF PLKPGVPLPS PEDLRGKILI KNKKNQFSGP TSSSKDTGGE
481 AEGSSPPSAP AGEGTVWAGE EGTELEEEEV EEEEEEESGN LDEEEIKKMQ SDEGTAGLEV
541 TAYEEMSSLV NYIQPTKFVS FEFSAQKNRS YVISSFTELK AYDLLSKASV QFVDYNKRQM
601 SRIYPKGTRM DSSNYMPQMF WNAGCQMVAL NFQTMDLPMQ QNMAVFEFNG QSGYLLKHEF
661 MRRPDKQFNP FSVDRIDVVV ATTLSITVIS GQFLSERSVR TYVEVELFGL PGDPKRRYRT
721 KLSPSTNSIN PVWKEEPFVF EKILMPELAS LRVAVMEEGN KFLGHRIIPI NALNSGYHHL
781 CLHSESNMPL TMPALFIFLE MKDYIPGAWA DLTVALANPI KFFSAHDTKS VKLKEAMGGL
841 PEKPFPLASP VASQVNGALA PTSNGSPAAR AGAREEAMKE AAEPRTASLE ELRELKGVVK
901 LQRRHEKELR ELERRGARRW EELLQRGAAQ LAELGPPGVG GVGACKLGPG KGSRKKRSLP
961 REESAGAAPG EGPEGVDGRV RELKDRLELE LLRQGEEQYE CVLKRKEQHV AEQISKMMEL
1021 AREKQAAELK ALKETSENDT KEMKKKLETK RLERIQGMTK VTTDKMAQER LKREINNSHI
1081 QEVVQVIKQM TENLERHQEK LEEKQAACLE QIREMEKQFQ KEALAEYEAR MKGLEAEVKE
1141 SVRACLRTCF PSEAKDKPER ACECPPELCE QDPLIAKADA QESRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLCB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 50 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 50 nTPM
- spleen: 38 nTPM
- appendix: 28 nTPM
- lymph node: 27 nTPM
- tonsil: 21 nTPM
- thymus: 19 nTPM
Single-cell type
- tuft cells: 173 nCPM
- microglia: 110 nCPM
- neutrophils: 84 nCPM
- monocytes: 61 nCPM
- cdc: 58 nCPM
- kupffer cells: 56 nCPM
Immune cell
- eosinophil: 5.3 nTPM
- neutrophil: 4.2 nTPM
- myeloid DC: 2.8 nTPM
- intermediate monocyte: 2.7 nTPM
- non-classical monocyte: 2.7 nTPM
- classical monocyte: 2.6 nTPM
Brain region
- white matter: 20 nTPM
- medulla oblongata: 19 nTPM
- thalamus: 16 nTPM
- pons: 16 nTPM
- midbrain: 13 nTPM
- spinal cord: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.51
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell chemotaxis
- detection of chemical stimulus involved in sensory perception of bitter taste
- G protein-coupled receptor signaling pathway
- lipid catabolic process
- phosphatidylinositol metabolic process
- phosphatidylinositol-mediated signaling
- phospholipase C-activating G protein-coupled receptor signaling pathway
- phospholipid metabolic process
- release of sequestered calcium ion into cytosol
Molecular functions
- calcium ion binding
- G-protein beta/gamma-subunit complex binding
- phosphatidylinositol phospholipase C activity
- phosphatidylinositol-4,5-bisphosphate phospholipase C activity
- phospholipase C activity
- phospholipid binding
Cellular components
- cytoplasm
- cytosol
- neuronal dense core vesicle
- G-protein beta/gamma-subunit complex
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Phosphatidylinositol-specific phospholipase C, X domain
- Phosphoinositide phospholipase C family
- Phospholipase C, phosphatidylinositol-specific, Y domain
- EF-hand domain pair
- Phospholipase C-beta, C-terminal domain
- Phosphatidylinositol-4, 5-bisphosphate phosphodiesterase beta
- PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily
- C2 domain superfamily
- PLC-beta, PH domain
- Phospholipase C-beta, C-terminal domain superfamily
- Phosphoinositide phospholipase C beta 1-4-like, EF-hand domain
- C2 domain
- Phosphatidylinositol-specific phospholipase C, Y domain
- Phosphatidylinositol-specific phospholipase C, X domain
- PLC-beta C terminal
- PH domain
- Phosphoinositide phospholipase C beta1-4-like EF-hand domain
- 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2, catalytic domain
- 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2, EF-hand domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLCB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLCB2 as an antibody target. Whether an autoantibody or antibody against PLCB2 could matter depends on whether native PLCB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLCB2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLCB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...